{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:33:09Z","timestamp":1791891189941,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd001798.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000}}],"reference-count":53,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001798.pub3","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T14:28:42Z","timestamp":1488205722000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Plasma exchange for Guillain-Barr\u00e9 syndrome"],"prefix":"10.1002","volume":"2017","author":[{"given":"Sylvie","family":"Chevret","sequence":"first","affiliation":[{"name":"H\u00f4pital Saint Louis; Departement de Biostatistique et Informatique M\u00e9dicale; 1 Avenue Claude Vellefaux 75475 Paris France Cedex 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; MRC Centre for Neuromuscular Diseases; PO Box 114 Queen Square London UK WC1N 3BG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[{"name":"H\u00f4pital Raymond Poincar\u00e9, Assistance Publique - H\u00f4pitaux de Paris; Critical Care Department; 104. Boulevard Raymond Poincar\u00e9 Garches Ile de France France 92380"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD001798.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.37.5.837","article-title":"Guillain Barr\u00e9 syndrome: quantitative measurement of plasma exchange therapy","volume":"37","author":"F\u00e4rkkil\u00e4","year":"1987","journal-title":"Neurology"},{"issue":"8382","key":"10.1002\/14651858.CD001798.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(84)91341-2","article-title":"Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"1","author":"Greenwood","year":"1984","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD001798.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","article-title":"Plasmapheresis and acute Guillain-Barr\u00e9 syndrome","volume":"35","author":"The Guillain-Barr\u00e9 syndrome study group","year":"1985","journal-title":"Neurology"},{"issue":"8415","key":"10.1002\/14651858.CD001798.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(84)90819-5","article-title":"Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"2","author":"Osterman","year":"1984","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD001798.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids","volume":"22","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome","year":"1987","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001798.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ana.410320115","article-title":"Plasma exchange in Guillain-Barr\u00e9 syndrome: one year follow-up","volume":"32","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome","year":"1992","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 Syndrome","volume":"41","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","year":"1997","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 Syndrome","volume":"41","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","year":"1997","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 Syndrome","volume":"41","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","year":"1997","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD001798.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jca.2920090212","article-title":"Manual plasmapheresis in the treatment of Guillain Barr\u00e9 syndrome","volume":"9","author":"de-Zoysa","year":"1994","journal-title":"Journal of Clinical Apheresis"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"El-Bayoumi MA El-Refaey AM Abdelkader AM El-Assmy MM Alwakeel AA El-Tahan HM Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barr\u00e9 Syndrome. A randomized study Critical Care 2011 R164","DOI":"10.1186\/cc10305"},{"issue":"11","key":"10.1002\/14651858.CD001798.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.35.11.1551","article-title":"Plasma exchange and prednisone in Guillain-Barr\u00e9 syndrome: a controlled randomised trial","volume":"35","author":"Mendell","year":"1985","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"M638","DOI":"10.1097\/00002480-199407000-00076","article-title":"Plasmapheresis versus plasma perfusion in acute Guillain-Barr\u00e9 syndrome","volume":"40","author":"Morosetti","year":"1994","journal-title":"ASAIO Journal"},{"issue":"4","key":"10.1002\/14651858.CD001798.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1098-1101(1997)12:4<165::AID-JCA2>3.0.CO;2-8","article-title":"Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group","volume":"12","author":"Rock","year":"1997","journal-title":"Journal of Clinical Apheresis"},{"issue":"5","key":"10.1002\/14651858.CD001798.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1212\/WNL.57.5.774","article-title":"CSF filtration is an effective treatment of Guillain Barr\u00e9 syndrome: a randomized clinical trial","volume":"57","author":"Wollinsky","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27 Suppl","author":"Asbury","year":"1990","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001798.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00003246-199305000-00006","article-title":"Plasma exchange morbidity in Guillain Barr\u00e9 syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group","volume":"21","author":"Bouget","year":"1993","journal-title":"Critical Care Medicine"},{"issue":"8099","key":"10.1002\/14651858.CD001798.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(78)91837-8","article-title":"Treatment of acute polyneuropathy by plasma exchange","volume":"2","author":"Brettle","year":"1978","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD001798.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.1986.03380100107031","article-title":"The utility of therapeutic plasmapheresis for neurological disorders","volume":"256","author":"Consensus","year":"1986","journal-title":"Journal of the American Medical Association"},{"issue":"2","key":"10.1002\/14651858.CD001798.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archneur.1971.00480320064006","article-title":"Circulating demyelinating factors in acute idiopathic polyneuropathy","volume":"24","author":"Cook","year":"1971","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1002\/14651858.CD001798.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s001340051323","article-title":"Cost-effectiveness of plasma exchange therapy for the treatment of Guillain-Barr\u00e9 syndrome","volume":"26","author":"Esp\u00e9rou","year":"2000","journal-title":"Intensive Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD001798.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2648.1992.tb01963.x","article-title":"Plasma exchange therapy reduces the nursing care needed in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Farkkila","year":"1992","journal-title":"Journal of Advanced Nursing"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0024|cit24","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro 2008"},{"issue":"2","key":"10.1002\/14651858.CD001798.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ana.410150209","article-title":"Demyelination induced by serum from patients with Guillain-Barr\u00e9 syndrome","volume":"15","author":"Harrison","year":"1984","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0026|cit26","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"8104-5","key":"10.1002\/14651858.CD001798.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial of prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"issue":"Pt 9","key":"10.1002\/14651858.CD001798.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008630.pub2","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barr\u00e9 syndrome","author":"Hughes","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD001798.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002063.pub6","article-title":"Intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome","author":"Hughes","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD001798.pub3-BIB0031|cit31","first-page":"361","article-title":"Plasmapheresis in idiopathic inflammatory polyradiculoneuropathy","volume":"30","author":"Mark","year":"1980","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jca.2920020416","article-title":"The North American study of plasmapheresis in the Guillain-Barr\u00e9 syndrome","volume":"2","author":"The Guillain-Barr\u00e9 Syndrome Study Group","year":"1985","journal-title":"Journal of Clinical Apheresis"},{"issue":"4","key":"10.1002\/14651858.CD001798.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.410230406","article-title":"Plasmapheresis and Guillain-Barr\u00e9 syndrome: analysis of prognostic factors and the effect of plasmapheresis","volume":"23","author":"McKhann","year":"1988","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD001798.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jca.2920020419","article-title":"Plasma exchange and prednisone in acute inflammatory polyradiculoneuropathy: a controlled randomized trial","volume":"2","author":"Mendell","year":"1985","journal-title":"Journal of Clinical Apheresis"},{"issue":"4","key":"10.1002\/14651858.CD001798.pub3-BIB0035|cit35","first-page":"312","article-title":"Serum demyelinating activity and Guillain-Barre syndrome: favorable effect of plasma exchange","volume":"145","author":"Metral","year":"1989","journal-title":"Revue Neurologique"},{"issue":"9047","key":"10.1002\/14651858.CD001798.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0037|cit37","first-page":"603","article-title":"Cooperative randomized trial of plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"6","author":"Raphael","year":"1985","journal-title":"Plasma Therapy and Transfusion Technology"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0038|cit38","first-page":"329","article-title":"Cooperative randomized trial of plasma exchange in the Guillain-Barr\u00e9 syndrome. Short term effects and comparison of diluted albumin and fresh frozen plasma","volume":"4","author":"Raphael","year":"1986","journal-title":"Life Support System"},{"issue":"1","key":"10.1002\/14651858.CD001798.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ana.410320115","article-title":"Plasma exchange in Guillain-Barr\u00e9 syndrome: one-year follow-up","volume":"32","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome","year":"1992","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001798.pub3-BIB0040|cit40","first-page":"359","article-title":"Treatment of Guillain-Barr\u00e9 syndrome by plasma exchange: proposal of a therapeutic strategy","volume":"152","author":"Rapha\u00ebl","year":"1996","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0041|cit41","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0042|cit42","first-page":"361","article-title":"Improvement in four patients with acute Guillain-Barr\u00e9 syndrome after plasma exchange","volume":"30","author":"Ropper","year":"1980","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0043|cit43","first-page":"117","article-title":"Plasma exchange in Guillain-Barr\u00e9 syndrome ten cases","volume":"2","author":"Schooneman","year":"1981","journal-title":"Plasmapheresis Therapy"},{"issue":"1212","key":"10.1002\/14651858.CD001798.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM198403223101206","article-title":"Therapeutic plasma exchange","volume":"310","author":"Shumak","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001798.pub3-BIB0045|cit45","first-page":"17","article-title":"Electrophysiological and morphological effects of the injection of Guillain-Barr\u00e9 sera in the sciatic nerve of the rat","volume":"138","author":"Sumner","year":"1982","journal-title":"Revue Neurologique"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0046|cit46","first-page":"74","article-title":"Plasma exchange as a therapy for Guillain-Barr\u00e9 syndrome with immune complexes","volume":"41","author":"Valbonesi","year":"1981","journal-title":"Vox Sanguinis"},{"issue":"17","key":"10.1002\/14651858.CD001798.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome","volume":"326","author":"Mech\u00e9","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001798.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.53.3.598","article-title":"Prognostic factors of Guillain-Barr\u00e9 syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barr\u00e9 Study Group","volume":"53","author":"Visser","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001798.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD001798.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001798.pub3-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798.pub2","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Rapha\u00ebl","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001798.pub3-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Rapha\u00ebl","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001798.pub3-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","author":"Rapha\u00ebl","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001798.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T03:47:14Z","timestamp":1734493634000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001798.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001798.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]}}}